🇺🇸 FDA
Pipeline program

Plozasiran Injection

AROAPOC3-3003

Phase 3 small_molecule active

Quick answer

Plozasiran Injection for Severe Hypertriglyceridemia is a Phase 3 program (small_molecule) at ARROWHEAD PHARMACEUTICALS, INC. with 2 ClinicalTrials.gov record(s).

Program details

Company
ARROWHEAD PHARMACEUTICALS, INC.
Indication
Severe Hypertriglyceridemia
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials